The National Heart, Lung, and Blood Institute (NHLBI), National Institutes of Health (NIH) has made two awards as part of its Program of Excellence in Nanotechnology. The Georgia Institute of Technology and Emory University will together receive $11.5 million over five years to establish a new research program focused on creating advanced nanotechnologies to analyze plaque formation on the molecular level and detect plaque at its early stages. The prime focus of the five-year award of $12.5 million to Washington University in St. Louis is the development of nanoscale agents that can be assembled, labeled, targeted, filled and activated for eventual diagnosis and treatment of various diseases relevant to NHLBI.
Close Page- Text Size: A A A
Printer Friendly
